Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

52 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

NCT01248923

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

NCT02632786

Conditions
AL Amyloidosis, Alzheimer Disease, Amyloidosis, +22 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute (SCI) Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 40 locations
View Trial Details
Completed

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

NCT00079716

Conditions
Blood Coagulation Disorders, Blood Protein Disorders, Cardiovascular Diseases, +14 more
Locations
  • James R. Berenson M.D., Inc. West Hollywood, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cornell University New York, United States
View Trial Details
Completed

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

NCT00525447

Conditions
Blood Coagulation Disorders, Blood Protein Disorders, Cardiovascular Diseases, +14 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions